GB202209624D0 - Prodrugs - Google Patents

Prodrugs

Info

Publication number
GB202209624D0
GB202209624D0 GBGB2209624.2A GB202209624A GB202209624D0 GB 202209624 D0 GB202209624 D0 GB 202209624D0 GB 202209624 A GB202209624 A GB 202209624A GB 202209624 D0 GB202209624 D0 GB 202209624D0
Authority
GB
United Kingdom
Prior art keywords
prodrugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2209624.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Original Assignee
Institute of Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research filed Critical Institute of Cancer Research
Priority to GBGB2209624.2A priority Critical patent/GB202209624D0/en
Publication of GB202209624D0 publication Critical patent/GB202209624D0/en
Priority to PCT/GB2023/051702 priority patent/WO2024003558A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
GBGB2209624.2A 2022-06-30 2022-06-30 Prodrugs Ceased GB202209624D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2209624.2A GB202209624D0 (en) 2022-06-30 2022-06-30 Prodrugs
PCT/GB2023/051702 WO2024003558A1 (en) 2022-06-30 2023-06-29 Prodrugs of lysyl oxidase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2209624.2A GB202209624D0 (en) 2022-06-30 2022-06-30 Prodrugs

Publications (1)

Publication Number Publication Date
GB202209624D0 true GB202209624D0 (en) 2022-08-17

Family

ID=82802663

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2209624.2A Ceased GB202209624D0 (en) 2022-06-30 2022-06-30 Prodrugs

Country Status (2)

Country Link
GB (1) GB202209624D0 (en)
WO (1) WO2024003558A1 (en)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10216144A1 (en) 2002-04-12 2003-11-06 Bayer Ag New 2-phenyl-4-phenoxy-3(2H)-pyridazinone derivatives useful as lysyl oxidase inhibitors for preventing or treating fibrotic diseases
GB0423554D0 (en) 2004-10-22 2004-11-24 Cancer Rec Tech Ltd Therapeutic compounds
US9161922B2 (en) 2005-07-01 2015-10-20 Case Western Reserve University Amine oxidase inhibitors
KR101665143B1 (en) 2007-12-19 2016-10-11 캔써 리서치 테크놀로지 리미티드 Pyrido[2,3-b]pyrazine-8-substituted compounds and their use
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
JP2012517438A (en) 2009-02-06 2012-08-02 アレスト バイオサイエンシズ，インク． Methods and compositions for the treatment of angiogenesis
RU2012110587A (en) 2009-08-21 2013-09-27 Джилид Байолоджикс, Инк. THERAPEUTIC METHODS AND COMPOSITIONS
US20110044907A1 (en) 2009-08-21 2011-02-24 Derek Marshall In vivo screening assays
KR20120091146A (en) 2009-09-29 2012-08-17 길리아드 바이오로직스, 인크. Methods and compositions for treatment of ocular fibrosis
CN102906090B (en) 2010-02-01 2015-06-24 癌症研究技术有限公司 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
WO2012139045A1 (en) 2011-04-08 2012-10-11 Gilead Biologics, Inc. Methods and compositions for normalization of tumor vasculature by inhibition of loxl2
WO2014152122A2 (en) 2013-03-15 2014-09-25 Children's Medical Center Corporation Methods of altering vascular permeability and uses thereof
GB201320729D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Therapeutic compounds and their use
MX2017011269A (en) 2015-03-06 2018-01-12 Pharmakea Inc Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof.
CN107624110B (en) 2015-03-06 2021-01-26 法玛克亚公司 Lysyl oxidase-like 2 inhibitors and uses thereof
WO2017003862A1 (en) 2015-07-01 2017-01-05 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
WO2017015221A1 (en) 2015-07-23 2017-01-26 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
GB201602934D0 (en) 2016-02-19 2016-04-06 Cancer Res Inst Royal Compounds
CN114286816A (en) 2019-07-25 2022-04-05 法玛西斯有限公司 Difluoro-halogenated allylamine sulfone derivative inhibitor of lysyl oxidase, preparation method and application thereof

Also Published As

Publication number Publication date
WO2024003558A1 (en) 2024-01-04

Similar Documents

Publication Publication Date Title
CA216403S (en) Hoodie
IL290164A (en) Treprostinil prodrugs
GB202213162D0 (en) Prodrugs
GB202209624D0 (en) Prodrugs
CA217438S (en) Footwarmer
CA215379S (en) E-track
CA215433S (en) Thermo-hygrometer
CA215434S (en) Thermo-hygrometer
GB202218027D0 (en) Psilocin prodrugs
GB202210427D0 (en) Psilocin prodrugs
GB202210069D0 (en) Hyperconducting arrangement
GB202317385D0 (en) gec37-onorina cristoforo-c2023nov15-f2023nov5-5gd
GB202213489D0 (en) Anjitsusohryakuteionlyvaigaligaligalishohryak-avaiavalicagachachatchaman-aidohn15circlexdotgachachatchamanaidohn15circlexdotkanjitsunosohryak-uteivai133millio
GB202212086D0 (en) Hasshalettsgohletsudanvai gachachatchamanaidohn12Circlexdot
GB202211746D0 (en) Gozakacchongozaso-hteiquezonematamatamatajuhjikivaizone
GB202211719D0 (en) Kaijitsudonmai
GB202211668D0 (en) Exwg-olayemi-c2022jul1-f2022jul27-tbs
GB202211340D0 (en) Kanjitsuhajuhjikivai
GB202211339D0 (en) Kanjitsuhajuhjikivai
GB202211182D0 (en) Bead-hashing
GB202210960D0 (en) Tees-Lashin
GB202211010D0 (en) Akorker
GB202210274D0 (en) Withim
GB202209344D0 (en) Hdroponics
GB202208989D0 (en) Drydam

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)